127 related articles for article (PubMed ID: 8636570)
1. Neuropeptide Y modulation of sympathetic activity in myocardial infarction.
Basu S; Sinha SK; Shao Q; Ganguly PK; Dhalla NS
J Am Coll Cardiol; 1996 Jun; 27(7):1796-803. PubMed ID: 8636570
[TBL] [Abstract][Full Text] [Related]
2. Altered neuropeptide Y effects on noradrenaline levels in the paraventricular nucleus of rats following aortic constriction.
Woo ND; Ganguly PK
Can J Cardiol; 1994 May; 10(4):471-6. PubMed ID: 8193992
[TBL] [Abstract][Full Text] [Related]
3. Norepinephrine levels in paraventricular nucleus of spontaneously hypertensive rats: role of neuropeptide Y.
Woo ND; Mukherjee K; Ganguly PK
Am J Physiol; 1993 Sep; 265(3 Pt 2):H893-8. PubMed ID: 8214124
[TBL] [Abstract][Full Text] [Related]
4. Hypothalamic Paraventricular and Arcuate Nuclei Contribute to Elevated Sympathetic Nerve Activity in Pregnant Rats: Roles of Neuropeptide Y and α-Melanocyte-Stimulating Hormone.
Shi Z; Cassaglia PA; Gotthardt LC; Brooks VL
Hypertension; 2015 Dec; 66(6):1191-8. PubMed ID: 26483343
[TBL] [Abstract][Full Text] [Related]
5. Role of the Paraventricular Nucleus of the Hypothalamus in the Sympathoexcitatory Effects of Leptin.
Shi Z; Li B; Brooks VL
Hypertension; 2015 Nov; 66(5):1034-41. PubMed ID: 26370892
[TBL] [Abstract][Full Text] [Related]
6. Brain perivascular macrophages and the sympathetic response to inflammation in rats after myocardial infarction.
Yu Y; Zhang ZH; Wei SG; Serrats J; Weiss RM; Felder RB
Hypertension; 2010 Mar; 55(3):652-9. PubMed ID: 20142564
[TBL] [Abstract][Full Text] [Related]
7. Role of neuropeptide Y in renal sympathetic vasoconstriction: studies in normal and congestive heart failure rats.
DiBona GF; Sawin LL
J Lab Clin Med; 2001 Aug; 138(2):119-29. PubMed ID: 11477379
[TBL] [Abstract][Full Text] [Related]
8. Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans.
Morris MJ; Cox HS; Lambert GW; Kaye DM; Jennings GL; Meredith IT; Esler MD
Hypertension; 1997 Jan; 29(1 Pt 1):137-43. PubMed ID: 9039093
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y and [Leu31,Pro34]neuropeptide Y potentiate potassium-induced noradrenaline release in the paraventricular nucleus of the aged rat.
Hastings JA; Pavia JM; Morris MJ
Brain Res; 1997 Mar; 750(1-2):301-4. PubMed ID: 9098556
[TBL] [Abstract][Full Text] [Related]
10. [Downregulation of large conductance calcium-activated potassium channels in paraventricular nucleus contributes to sympathoexcitation in rats with chronic heart failure].
Wang RJ; Wen ML; Zhou Q; Wei XW; Li H; Zhao YB; Qi YF; Luan J; Zhou XF
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Mar; 46(3):178-186. PubMed ID: 29562421
[No Abstract] [Full Text] [Related]
11. Modulation of sympathetic activity by brain neuropeptide Y in cardiac hypertrophy.
Woo ND; Sahai A; Anderson WA; Ganguly PK
Am Heart J; 1991 Oct; 122(4 Pt 1):1028-34. PubMed ID: 1833961
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of the sympathetic perimesenteric arterial nerves releases neuropeptide Y potentiating the vasomotor activity of noradrenaline: involvement of neuropeptide Y-Y1 receptors.
Donoso MV; Brown N; Carrasco C; Cortes V; Fournier A; Huidobro-Toro JP
J Neurochem; 1997 Sep; 69(3):1048-59. PubMed ID: 9282927
[TBL] [Abstract][Full Text] [Related]
13. Effect of the changes of NMDA receptor in hypothalamic paraventricular nucleus on cardiac function and sympathetic nervous activity in rats with heart failure.
Sun Y; Sun B; He R
Biochem Biophys Res Commun; 2017 Nov; 493(3):1336-1341. PubMed ID: 28958939
[TBL] [Abstract][Full Text] [Related]
14. Alpha2-adrenoceptor-mediated restraint of norepinephrine synthesis, release, and turnover during immobilization in rats.
Tjurmina OA; Goldstein DS; Palkovits M; Kopin IJ
Brain Res; 1999 May; 826(2):243-52. PubMed ID: 10224302
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of galanin and neuropeptide Y on extracellular norepinephrine levels in the paraventricular hypothalamic nucleus of the rat: a microdialysis study.
Kyrkouli SE; Stanley BG; Leibowitz SF
Life Sci; 1992; 51(3):203-10. PubMed ID: 1377322
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y infusion decreases plasma renin activity in postmyocardial infarction rats.
Zelis R; Nussberger J; Clemson B; Waeber B; Grouzmann E; Brunner HR
J Cardiovasc Pharmacol; 1994 Dec; 24(6):896-9. PubMed ID: 7898071
[TBL] [Abstract][Full Text] [Related]
17. Differential changes in sympathetic activity in left and right ventricles in congestive heart failure after myocardial infarction.
Ganguly PK; Dhalla KS; Shao Q; Beamish RE; Dhalla NS
Am Heart J; 1997 Mar; 133(3):340-5. PubMed ID: 9060804
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y potentiation of potassium-induced noradrenaline release in the hypothalamic paraventricular nucleus of the rat in vivo.
Pavia JM; Hastings JA; Morris MJ
Brain Res; 1995 Aug; 690(1):108-11. PubMed ID: 7496795
[TBL] [Abstract][Full Text] [Related]
19. Alteration of NMDA NR1 receptors within the paraventricular nucleus of hypothalamus in rats with heart failure.
Li YF; Cornish KG; Patel KP
Circ Res; 2003 Nov; 93(10):990-7. PubMed ID: 14576197
[TBL] [Abstract][Full Text] [Related]
20. Intracerebroventricular administration of neuropeptide Y inhibits release of noradrenaline in the hypothalamic paraventricular nucleus caused by manual restraint in the rat through an opioid system.
Shibasaki T; Tsumori C; Hotta M; Imaki T; Demura H
Brain Res; 1995 Aug; 688(1-2):189-92. PubMed ID: 8542306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
